Goldman Sachs
ONCE

Goldman Sachs’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Goldman Sachs’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,000
Closed -$2.06M – 6587
2017
Q4 		$2.06M Buy
40,000
+39,600
+9,900% +$2.84M ﹤0.01% 3784
2017
Q3 		$36K Sell
400
-2,400
-86% -$182K ﹤0.01% 6332
2017
Q2 		$167K Buy
2,800
+1,100
+65% +$61.5K ﹤0.01% 5897
2017
Q1 		$91K Buy
1,700
+1,000
+143% +$59.4K ﹤0.01% 6096
2016
Q4 		$35K Sell
700
-66,900
-99% -$3.58M ﹤0.01% 6488
2016
Q3 		$4.06M Buy
67,600
+66,400
+5,533% +$3.83M ﹤0.01% 3220
2016
Q2 		$61K Sell
1,200
-46,400
-97% -$1.98M ﹤0.01% 6350
2016
Q1 		$1.41M Buy
47,600
+7,200
+18% +$227K ﹤0.01% 3793
2015
Q4 		$1.83M Buy
40,400
+34,300
+562% +$1.8M ﹤0.01% 3713
2015
Q3 		$255K Buy
6,100
+5,500
+917% +$287K ﹤0.01% 5760
2015
Q2 		$36K Buy
+600
New +$39.7K ﹤0.01% 6959

Goldman Sachs's ONCE Position: Q4 2019 in Review

Goldman Sachs sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 494,248 shares — an estimated $47.9M sold.

Goldman Sachs first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $129M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Goldman Sachs reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Goldman Sachs sold 494,248 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $47.9M.
  • Goldman Sachs first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
  • Goldman Sachs's Spark Therapeutics, Inc. Common Stock position peaked at $129M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.